OpenURL Connection Search

Select item for more details and to access through your institution.

RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 117, doi. 10.1002/hon.77_2629
By:
- Delfau‐Larue, M.H.;
- Boulland, M.L.;
- Feugier, P.;
- Maisonneuve, H.;
- Casasnovas, O.;
- Haioun, C.;
- Pica, G.M.;
- Lamy de la Chapelle, T.;
- Ysebaert, L.;
- Tilly, H.;
- Eisenmann, J.C.;
- Le Gouil, S.;
- Ribrag, V.;
- Jardel, H.;
- Glaisner, S.;
- Cartron, G.;
- Salles, G.;
- Xerri, L.;
- Fest, T.;
- Morschhauser, F.
Publication type:
Article
RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 117, doi. 10.1002/hon.77_2629
By:
- Delfau‐Larue, M.H.;
- Boulland, M.L.;
- Feugier, P.;
- Maisonneuve, H.;
- Casasnovas, O.;
- Haioun, C.;
- Pica, G.M.;
- Lamy de la Chapelle, T.;
- Ysebaert, L.;
- Tilly, H.;
- Eisenmann, J.C.;
- Le Gouil, S.;
- Ribrag, V.;
- Jardel, H.;
- Glaisner, S.;
- Cartron, G.;
- Salles, G.;
- Xerri, L.;
- Fest, T.;
- Morschhauser, F.
Publication type:
Article
SERUM 2-HYDROXYGLUTARATE, A PREDICTIVE BIOMARKER OF THE PRESENCE OF IDH2 MUTATIONS IN AITL PATIENTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 392, doi. 10.1002/hon.2439_158
By:
- Broutin, S.;
- Dupuy, A.;
- Koscielny, S.;
- Fataccioli, V.;
- Lemonnier, F.;
- Leval, L.;
- Robe, C.;
- Pujals, A.;
- Safar, V.;
- Delarue, R.;
- Delfau ‐ Larue, M.H.;
- Ribrag, V.;
- Haioun, C.;
- Gaulard, P.;
- Paci, A.
Publication type:
Article
BASELINE CIRCULATING CELL-FREE DNA LOAD IS RELATED TO, BUT ADDS PROGNOSTIC VALUE TO METABOLIC TUMOR BURDEN MEASURED BY FDG PET/CT IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 95, doi. 10.1002/hon.2437_84
By:
- Delfau ‐ Larue, M.H.;
- Benmaad, I.;
- Robert, P.;
- Hamdane, S.;
- Nel, I.;
- Dupuis, J.;
- Haioun, C.;
- Berriolo Riedinger, A.;
- Casasnovas, R.O.;
- Itti, E.
Publication type:
Article
LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: a LYSA STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 98, doi. 10.1002/hon.2437_87
By:
- Delfau ‐ Larue, M.H.;
- Beldi ‐ Ferchiou, A.;
- Jais, J.;
- Godard, N.;
- Salles, G.A.;
- Casasnovas, R.;
- Tilly, H.;
- Fruchart, C.;
- Morschhauser, F.;
- Haioun, C.;
- Lazarovici, J.;
- Perrot, A.;
- Sebban, C.;
- Bouabdallah, R.;
- Gonzalez, H.;
- Corront, B.;
- Oberic, L.;
- Briere, J.;
- Gaulard, P.;
- Coiffier, B.
Publication type:
Article
Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a patient with Sézary syndrome treated by methotrexate.
Published in:
British Journal of Dermatology, 2016, v. 175, n. 2, p. 430, doi. 10.1111/bjd.14602
By:
- Ingen ‐ Housz ‐ Oro, S.;
- Ortonne, N.;
- Cordel, N.;
- Moroch, J.;
- Do ‐ Pham, G.;
- Delfau, M.H.;
- Haioun, C.;
- Chosidow, O.
Publication type:
Article
Leucoderma associated with flares of erythrodermic cutaneous T-cell lymphomas: four cases.
Published in:
British Journal of Dermatology, 2000, v. 143, n. 4, p. 832, doi. 10.1046/j.1365-2133.2000.03851.x
By:
- Bouloc, A.;
- Grange, F.;
- Delfau-Larue, M.H.;
- Dieng, M.T.;
- Tortel, M.C.;
- Avril, M.F.;
- Revuz, J.;
- Bagot, M.;
- Wechsler, J.;
- For The French Study Group Of Cutaneous Lymphomas
Publication type:
Article

Found: 7

RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY.

RITUXIMAB PLUS LENALIDOMIDE IS AS EFFECTIVE AS IMMUNOCHEMOTHERAPY IN THE ERADICATION OF MOLECULAR DISEASE IN UNTREATED FOLLICULAR LYMPHOMA: RELEVANCE LYSA ANCILLARY STUDY.

SERUM 2-HYDROXYGLUTARATE, A PREDICTIVE BIOMARKER OF THE PRESENCE OF IDH2 MUTATIONS IN AITL PATIENTS.

BASELINE CIRCULATING CELL-FREE DNA LOAD IS RELATED TO, BUT ADDS PROGNOSTIC VALUE TO METABOLIC TUMOR BURDEN MEASURED BY FDG PET/CT IN FOLLICULAR LYMPHOMA.

LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: a LYSA STUDY.

Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a patient with Sézary syndrome treated by methotrexate.

Leucoderma associated with flares of erythrodermic cutaneous T-cell lymphomas: four cases.